UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Role of Religiosity and Spirituality in Helping Polish Subjects Adapt to Their Tinnitus

Journal of religion and health, 2023-04, Vol.62 (2), p.1251-1268

2023

Volltextzugriff (PDF)

E112 Parenting a deaf child and coping with stress

International journal of pediatric otorhinolaryngology, 2011, Vol.75, p.81-81

2011

Volltextzugriff (PDF)

A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM

The New England journal of medicine, 1995-06, Vol.332 (25), p.1661

1995

Volltextzugriff (PDF)

Renal toxicity of intravenous immunoglobulin

Clinical nephrology, 1992-04, Vol.37 (4), p.216

1992

Volltextzugriff (PDF)

Prevention of heart embolism in low-risk patients is expensive

Läkartidningen, 1996-10, Vol.93 (44), p.3885-3886

Kobosko, J

1996

Volltextzugriff (PDF)

Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene

Human genetics, 1992-03, Vol.88 (5), p.586-588

1992

Volltextzugriff (PDF)

The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism

Thrombosis and haemostasis, 1996, Vol.75 (4), p.607-611

1996

Volltextzugriff (PDF)

Quality of oral anticoagulant control and treatment in Sweden

Journal of internal medicine, 1994-08, Vol.236 (2), p.143-152

SCHULMAN, S.

1994

Volltextzugriff (PDF)

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group

The New England journal of medicine, 1997-02, Vol.336 (6), p.393-398

1997

Volltextzugriff (PDF)

Protein C deficiency and thrombomembolism : recurrent mutation at Arg 306 in the protein C gene

Human genetics, 1992, Vol.88 (5), p.586-588

1992

Volltextzugriff (PDF)

The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group

Thrombosis and haemostasis, 1996-04, Vol.75 (4), p.607

1996

Volltextzugriff (PDF)

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group

The New England journal of medicine, 1995-06, Vol.332 (25), p.1661-1665

1995

Volltextzugriff (PDF)

Passing an Enhanced Turing Test – Interacting with Lifelike Computer Representations of Specific Individuals

Journal of intelligent systems, 2013-12, Vol.22 (4), p.365-415

2013

Volltextzugriff (PDF)

Passing an Enhanced Turing Test – Interacting with Lifelike Computer Representations of Specific Individuals

Journal of intelligent systems, 2014-09, Vol.23 (3), p.357-357

2014

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(14)

Sprache

Englisch
(13)
Schwedisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The Role of Religiosity and Spirituality in Helping Polish Subjects Adapt to Their Tinnitus

E112 Parenting a deaf child and coping with stress

A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM

Renal toxicity of intravenous immunoglobulin

Prevention of heart embolism in low-risk patients is expensive

Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene

The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism

Quality of oral anticoagulant control and treatment in Sweden

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group

Protein C deficiency and thrombomembolism : recurrent mutation at Arg 306 in the protein C gene

The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group

Passing an Enhanced Turing Test – Interacting with Lifelike Computer Representations of Specific Individuals

Passing an Enhanced Turing Test – Interacting with Lifelike Computer Representations of Specific Individuals

Suchergebnisse filtern